Home › Funds › BlackRock Inc › PLRX
BlackRock Inc position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.15M sh
Reported value held$1.31M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 5.22M | $58.50M | New |
| Q4 2024 | 5.18M | $68.22M | Reduce |
| Q1 2025 | 5.24M | $7.08M | Add |
| Q2 2025 | 2.13M | $2.47M | Reduce |
| Q3 2025 | 1.42M | $2.10M | Reduce |
| Q4 2025 | 1.07M | $1.31M | Reduce |
| Q1 2026 | 1.10M | $1.38M | Add |
| Q2 2026 | 1.15M | $1.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Citadel Advisors 2.14M sh · $2.44M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- Marshall Wace 835.12K sh · $952.04K · Q2 2026
- JPMorgan Chase & Co 681.65K sh · $783.89K · Q2 2026
- Geode Capital Management 578.58K sh · $659.95K · Q2 2026
- UBS Group AG 571.76K sh · $651.81K · Q2 2026
- Millennium Management 559.45K sh · $637.77K · Q2 2026
- Morgan Stanley 298.98K sh · $340.83K · Q2 2026
- Goldman Sachs Group 208.59K sh · $237.79K · Q2 2026